Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials

BACKGROUND: DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A formulation approved for the treatment of glabellar lines. The efficacy, safety, and extended duration of response of DAXI 40 U for glabellar lines were demonstrated in 2 Phase 3, randomized, double-blind studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Solish, Nowell, Burgess, Cheryl M, Weinkle, Susan H, Ablon, Glynis, Brown, Jessica, Kooken, Kristie, Rubio, Roman G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896135/
https://www.ncbi.nlm.nih.gov/pubmed/36087303
http://dx.doi.org/10.1093/asj/sjac246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896135/
https://www.ncbi.nlm.nih.gov/pubmed/36087303
http://dx.doi.org/10.1093/asj/sjac246

Ejemplares similares